Literature DB >> 28971726

Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells.

Hima V Vangapandu1,2, Huiqin Chen3, William G Wierda4, Michael J Keating4, Anil Korkut5, Varsha Gandhi1,2,3.   

Abstract

Chronic lymphocytic leukemia (CLL) is an indolent B-cell malignancy in which cells reside in bone marrow, lymph nodes, and peripheral blood, each of which provides a unique microenvironment. Although the levels of certain proteins are reported to induce, changes in the CLL cell proteome in the presence of bone marrow stromal cells have not been elucidated. Reverse-phase protein array analysis of CLL cells before and 24 h after stromal cell interaction revealed changed levels of proteins that regulate cell cycle, gene transcription, and protein translation. The most hit with respect to both the extent of change in expression level and statistical significance was caveolin-1, which was confirmed with immunoblotting. Caveolin-1 mRNA levels were also upregulated in CLL cells after stromal cell interaction. The induction of caveolin-1 levels was rapid and occurred as early as 1 h. Studies to determine the significance of upregulated caveolin-1 levels in CLL lymphocytes are warranted.

Entities:  

Keywords:  CLL; Caveolin-1; duvelisib; microenvironment; proteomics; stroma

Mesh:

Substances:

Year:  2017        PMID: 28971726      PMCID: PMC5882591          DOI: 10.1080/10428194.2017.1376747

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  58 in total

1.  Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung.

Authors:  Phil Oh; Per Borgström; Halina Witkiewicz; Yan Li; Bengt J Borgström; Adrian Chrastina; Koji Iwata; Kurt R Zinn; Richard Baldwin; Jacqueline E Testa; Jan E Schnitzer
Journal:  Nat Biotechnol       Date:  2007-03-04       Impact factor: 54.908

2.  Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo.

Authors:  W Schubert; P G Frank; B Razani; D S Park; C W Chow; M P Lisanti
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

3.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia.

Authors:  Viralkumar Patel; Lisa S Chen; William G Wierda; Kumudha Balakrishnan; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2013-09-10

5.  Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.

Authors:  Karen N Wu; Maria Queenan; Jonathan R Brody; Magdalena Potoczek; Federica Sotgia; Michael P Lisanti; Agnieszka K Witkiewicz
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

6.  Differential expression of caveolin-1 in lipopolysaccharide-activated murine macrophages.

Authors:  M G Lei; D C Morrison
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

Authors:  Yair Herishanu; Patricia Pérez-Galán; Delong Liu; Angélique Biancotto; Stefania Pittaluga; Berengere Vire; Federica Gibellini; Ndegwa Njuguna; Elinor Lee; Lawrence Stennett; Nalini Raghavachari; Poching Liu; J Philip McCoy; Mark Raffeld; Maryalice Stetler-Stevenson; Constance Yuan; Richard Sherry; Diane C Arthur; Irina Maric; Therese White; Gerald E Marti; Peter Munson; Wyndham H Wilson; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

8.  Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow.

Authors:  Annie Pang; Wing Y Au; Yok L Kwong
Journal:  Leuk Res       Date:  2004-09       Impact factor: 3.156

9.  Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.

Authors:  Thomas M Herndon; Shih-Shih Chen; Nakhle S Saba; Janet Valdez; Claire Emson; Michelle Gatmaitan; Xin Tian; Thomas E Hughes; Clare Sun; Diane C Arthur; Maryalice Stetler-Stevenson; Constance M Yuan; Carsten U Niemann; Gerald E Marti; Georg Aue; Susan Soto; Mohammed Z H Farooqui; Sarah E M Herman; Nicholas Chiorazzi; Adrian Wiestner
Journal:  Leukemia       Date:  2017-01-11       Impact factor: 11.528

10.  Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Jan A Burger; Min Fu; Tejaswini Doifode; William G Wierda; Varsha Gandhi
Journal:  Neoplasia       Date:  2014-12       Impact factor: 5.715

View more
  3 in total

1.  Expression of the Cavin Family in Childhood Leukemia and Its Implications in Subtype Diagnosis and Prognosis Evaluation.

Authors:  Jing Yang; Junbin Huang; Huabin Wang; Yong Liu; Yanlai Tang; Chao Lin; Qin Zhou; Chun Chen
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

Review 2.  Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA.

Authors:  Jacob E Robinson; Christine E Cutucache
Journal:  Oncotarget       Date:  2018-07-06

3.  Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets.

Authors:  Ti'ara L Griffen; Fieke W Hoff; Yihua Qiu; James W Lillard; Alessandra Ferrajoli; Philip Thompson; Endurance Toro; Kevin Ruiz; Jan Burger; William Wierda; Steven M Kornblau
Journal:  Blood Cancer J       Date:  2022-03-17       Impact factor: 11.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.